Evaluation of polyelectrolyte multilayer thin-film coated microneedle arrays for transcutaneous vaccine delivery

Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2011. === Cataloged from PDF version of thesis. === Includes bibliographical references (p. 43-46). === The skin is an ideal organ for the safe and convenient delivery of vaccines, small molecules, a...

Full description

Bibliographic Details
Main Author: Fung, Peter W. (Peter Waitak)
Other Authors: Darrell J. Irvine.
Format: Others
Language:English
Published: Massachusetts Institute of Technology 2012
Subjects:
Online Access:http://hdl.handle.net/1721.1/69787
id ndltd-MIT-oai-dspace.mit.edu-1721.1-69787
record_format oai_dc
spelling ndltd-MIT-oai-dspace.mit.edu-1721.1-697872019-05-02T16:19:16Z Evaluation of polyelectrolyte multilayer thin-film coated microneedle arrays for transcutaneous vaccine delivery Fung, Peter W. (Peter Waitak) Darrell J. Irvine. Massachusetts Institute of Technology. Dept. of Materials Science and Engineering. Massachusetts Institute of Technology. Dept. of Materials Science and Engineering. Materials Science and Engineering. Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2011. Cataloged from PDF version of thesis. Includes bibliographical references (p. 43-46). The skin is an ideal organ for the safe and convenient delivery of vaccines, small molecules, and other biologics. Members of the Irvine and Hammond groups have developed a polyelectrolyte multilayer thin film-coated microneedle platform that can achieve simultaneous DNA and nanoparticle delivery. This delivery platform has the advantage of direct delivery of DNA or polymer nanoparticles to immune-active cells at the interface between the dermis and epidermis, enhancing uptake of the delivered cargo by resident immune cells. Ideal for the delivery of DNA vaccines, this platform aims to bridge the gap in the lack of efficient delivery platforms hampering the effectiveness of DNA vaccines. The ability to co-deliver polymer nanoparticles can serve as a conduit for delivering immune stimulating adjuvants or other drugs for therapeutic applications. An overview of current vaccine and delivery system research is presented. Market factors for the commercialization of the polyelectrolyte multilayer thin film-coated microneedle delivery platform are considered along with the risk factors in bringing this invention to market. An assessment of the intellectual property surrounding the platform is performed and a preliminary market entry strategy is developed for minimizing the risks commercialization. by Peter W. Fung. M.Eng. 2012-03-16T16:03:10Z 2012-03-16T16:03:10Z 2011 2011 Thesis http://hdl.handle.net/1721.1/69787 777363405 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 46 p. application/pdf Massachusetts Institute of Technology
collection NDLTD
language English
format Others
sources NDLTD
topic Materials Science and Engineering.
spellingShingle Materials Science and Engineering.
Fung, Peter W. (Peter Waitak)
Evaluation of polyelectrolyte multilayer thin-film coated microneedle arrays for transcutaneous vaccine delivery
description Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2011. === Cataloged from PDF version of thesis. === Includes bibliographical references (p. 43-46). === The skin is an ideal organ for the safe and convenient delivery of vaccines, small molecules, and other biologics. Members of the Irvine and Hammond groups have developed a polyelectrolyte multilayer thin film-coated microneedle platform that can achieve simultaneous DNA and nanoparticle delivery. This delivery platform has the advantage of direct delivery of DNA or polymer nanoparticles to immune-active cells at the interface between the dermis and epidermis, enhancing uptake of the delivered cargo by resident immune cells. Ideal for the delivery of DNA vaccines, this platform aims to bridge the gap in the lack of efficient delivery platforms hampering the effectiveness of DNA vaccines. The ability to co-deliver polymer nanoparticles can serve as a conduit for delivering immune stimulating adjuvants or other drugs for therapeutic applications. An overview of current vaccine and delivery system research is presented. Market factors for the commercialization of the polyelectrolyte multilayer thin film-coated microneedle delivery platform are considered along with the risk factors in bringing this invention to market. An assessment of the intellectual property surrounding the platform is performed and a preliminary market entry strategy is developed for minimizing the risks commercialization. === by Peter W. Fung. === M.Eng.
author2 Darrell J. Irvine.
author_facet Darrell J. Irvine.
Fung, Peter W. (Peter Waitak)
author Fung, Peter W. (Peter Waitak)
author_sort Fung, Peter W. (Peter Waitak)
title Evaluation of polyelectrolyte multilayer thin-film coated microneedle arrays for transcutaneous vaccine delivery
title_short Evaluation of polyelectrolyte multilayer thin-film coated microneedle arrays for transcutaneous vaccine delivery
title_full Evaluation of polyelectrolyte multilayer thin-film coated microneedle arrays for transcutaneous vaccine delivery
title_fullStr Evaluation of polyelectrolyte multilayer thin-film coated microneedle arrays for transcutaneous vaccine delivery
title_full_unstemmed Evaluation of polyelectrolyte multilayer thin-film coated microneedle arrays for transcutaneous vaccine delivery
title_sort evaluation of polyelectrolyte multilayer thin-film coated microneedle arrays for transcutaneous vaccine delivery
publisher Massachusetts Institute of Technology
publishDate 2012
url http://hdl.handle.net/1721.1/69787
work_keys_str_mv AT fungpeterwpeterwaitak evaluationofpolyelectrolytemultilayerthinfilmcoatedmicroneedlearraysfortranscutaneousvaccinedelivery
_version_ 1719038538373136384